血小板第4因子对辐射损伤小鼠免疫功能的保护作用

目的：探讨血小板第4因子（plateletfactor4，PF4）对辐射损伤小鼠免疫系统的影响。方法：雄性BALB／c小鼠随机分为3组，第1组（单纯照射组）、第Ⅱ组（PF4保护组）、第Ⅲ组（正常对照组），第Ⅱ组在照射前26h及20h腹腔注射PF440μg／kg，全身一次性5Gy60Co—γ射线照射后瑞氏染色法计数外周血淋巴细胞百分数。胸腺、脾脏制成细胞悬液计数后，MTT比色法测定胸腺及脾细胞增殖能力。结果：第Ⅱ组小鼠外周血淋巴细胞百分数下降趋势较第1组明显减慢。胸腺、脾细胞计数，第Ⅱ组明显高于第1组。淋巴细胞增殖试验，第Ⅱ组与第1组相比，小鼠胸腺及脾细胞的增殖能力明显增强。结论：PF4对免疫系统有辐射保护作用，可明显增强辐射损伤小鼠的免疫功能。     

Post-treatment sarcoma in breast cancer patients

Background: Many patients treated for breast cancer with radiotherapy will survive their disease and be at risk for treatment-related sarcoma for many years. Methods: In order to identify patients with post-treatment sarcoma and define this disease, we examined the records of 99 patients treated for sarcoma with a history of antecedent breast carcinoma. Of these patients, 51 were felt to have a sarcoma unrelated to breast cancer treatment and 48 were felt to have a treatment-related sarcoma (secondary to lymphedema and/or radiation). Results: Lymphangiosarcoma of the extremity was the most common histologic subtype of post-treatment sarcoma, accounting for 22 of 48 cases (46%). Twenty-six patients (54%) developed nonlymphangiosarcoma post-treatment sarcoma; all of these were radiation-associated sarcomas. The median latency interval between the diagnosis of breast cancer and the development of sarcoma was 11 years (range 4–44) and was not different between the two groups. However, patients with nonlymphangiosarcoma were significantly younger when diagnosed with breast cancer than were those with lymphangiosarcoma of the extremity (median 43 vs. 51 years, p<0.001). The survival of all 48 patients was poor: 5-year survival was 29%. Five-year survival of patients with other types of post-treatment sarcoma was just as poor as those with lymphangiosarcoma of the extremity (30% vs. 28%, p=0.98). Conclusions: Patients who develop sarcoma after treatment for breast cancer have a poor prognosis whether it occurs as Stewart-Treves syndrome or other types of post-treatment sarcoma. Younger patients may be at higher risk than are older patients for the development of nonlymphangiosarcoma post-treatment sarcoma.Presented at the 46th Annual Cancer Symposium of the Society of Surgical Oncology, Los Angeles, March 18–21, 1993.     

低剂量电离辐射对小鼠免疫器官cAMP和儿茶酚胺含量的影响

本文报道，７５ｍＧｙ／（１２．５ｍＧｙ／ｍｉｎ）单次全身Ｘ射线照射后９小时用ＳＲＢＣ免疫Ｃ５７ＢＬ／６小鼠，在免疫后４天和７天脾脏、胸腺和下丘脑ｃＡＭＰ含量均降低；而在免疫后４天脾脏去甲肾上腺素、肾上腺素和酪氨酸含量均增高，免疫后７天肾上腺素含量仍持续增高；当连接γ射线６５ｍＧｙ（０．０１５ｍＧｙ／ｍｉｎ，６ｈ／ｄ）全身照射小鼠后即刻或２９小时后免疫，脾脏和下丘脑ｃＡＭＰ含量也均降低。提示，低剂量     

碱性成纤维细胞生长因子对受照后大鼠血脑屏障的影响

目的评价定量检测放射性血脑屏障（BBB）破坏的不同方法，探讨碱性成纤维细胞生长因子（bFGF）对放射性BBB破坏的保护作用。方法60只急性放射性脑损伤模型大鼠（直线加速器6MeV电子束单次照射25Gy）分为单纯照射组和照射前尾静脉注射bFGF组（250ng／kg），并设未照射对照组；分别于照射后2、7和30d采用脑干-湿重法检测脑含水量，并用单次静脉注射3mg／kg伊文氏蓝（EB）后脑组织的EB含量法评估BBB破坏情况。结果照射后脑组织含水量和EB含量均较对照组明显增高，注射bFGF组脑组织含水量和EB含量均低于单纯照射组（P〈0．05）。受照后不同日期的脑组织EB含量差异有统计学意义（P〈0．05），而脑含水量差异没有统计学意义。结论注射EB后检测脑组织，浓度法较干湿重法测脑含水量能更好地反映BBB的破坏情况；bFGF对受照后BBB破坏有保护作用。     

慢性放射性肠炎并发肠梗阻的治疗

目的探讨放射性肠炎并发肠梗阻的治疗方法及临床效果。方法对2001年8月至2006年12月间收治的51例慢性放射性肠炎并发肠梗阻患者的临床资料进行总结。结果本组患者放射性肠炎并发肠梗阻均为肿瘤切除后盆腔、腹腔接受放射治疗所致,从放疗结束到肠梗阻症状出现的时间为(11.9±22.6)个月。分别采用了保守治疗(方案包括禁食、胃肠减压、抑制消化液分泌、营养支持、灌肠、补液、对症等,对于有感染征象的患者选用敏感的抗生素)、肠切除吻合术、肠造口术及短路手术。2例患者因肿瘤广泛转移未行有效手术治疗,1例患者术后因腹腔出血死亡,48例患者得到治愈,治愈率达94.1%。结论慢性放射性肠炎并发肠梗阻的治疗方案应该根据患者的营养状况及肠管损伤情况进行选择。     

甲基强的松龙和地塞米松治疗放射性脑水肿的差异

目的研究甲基强的松龙及地塞米松治疗放射性脑水肿的差异。方法建立大鼠脑胶质瘤模型。实验分组：A组（大剂量甲基强的松龙组）、B组（小剂量甲基强的松龙组）、C组（地塞米松组）、D组（对照组）、E组（空白组）。各组均颅内种植肿瘤，于种植15天后A、B、C、D各组给予C060照射，A、B、C组大鼠照射前后分别给予甲基强的松龙和地塞米松治疗。测量大鼠脑水肿情况。结果治疗后，与其他各组比较，D组大鼠脑组织含水率最高，E组最低（P〈0．05）；C组大鼠脑组织含水率明显高于A、B两组（P〈0．05）；但A、B两组间无显著性差异（P〉O．05）。结论甲基强的松龙和地塞米松都可以有效防治放射性脑水肿，且甲基强的松龙比地塞米松疗效更好。     

Renal growth and function 11–28 years after treatment of Wilms' tumour

In order to obtain more information on the long-term effects of treatment of Wilm's tumour we investigated 30 subjects treated at the Children's Hospital between 1960 and 1976. All had been nephrectomized and in 4 the length of the remaining kidney was subnormal. In the other subjects kidney length was related to follow up time and age at follow up. Blood pressure was elevated in 5 subjects. Urinary albumin excretion deviated only slightly from normal. Tubular functions were well preserved in all subjects. In this small series we were unable to establish any relation between the abnormalities observed and the treatment given. Our results suggest that, despite wide interindividual variation those who survive Wilm's tumours seldom have long-term renal complications.     

γ射线与噪声对豚鼠听觉损伤的复合效应

研究了γ射线（２０Ｇｙ）与噪声（１０５ｄＢＡ，３０ｍｉｎ）一次联合作用及６次重复联合作用（每次γ射线０．６７Ｇｙ，噪声１００ｄＢＡ，３０ｍｉｎ），对豚鼠听觉损伤的复合效应。结果表明，先γ射线２０Ｇｙ照射后噪声暴露对听觉损伤的复合效应是协同的。６次重复联合作用时，先噪声暴露后照射组的听阈偏移小于先照射后噪声暴露组；前者的复合效应为拮抗，后者为相加。本文对γ射线与噪声对听觉损伤联合作用的机理作了初步探讨。     

一例~(192)Ir极不均匀外照射局部极重度放射损伤的临床观察

目的对１例１９２Ｉｒ极不均匀外照射局部极重度放射损伤病人进行临床观察。方法系统观察了病变的临床过程和应用红外线热成像技术测定了损伤部位的温度变化。结果照射后２小时出现肢体麻木、抽搐，最早照后４小时出现红斑、肿胀，５４小时出现水疱，第５天出现坏死和剧痛，最晚出现红斑、肿胀是照射后４１天，４７天出现水疱和糜烂创面。红外线热成像显示：损伤早期温度升高，水疱、坏死区和损伤后期温度降低，温度升高越早，损伤越重，温度改变区域与损伤范围相一致。结论大剂量极不均匀外照射放射损伤的初期反应早，放射病与局部损伤相互加重病情，症状先后不一，轻重不等，致残率高和疼痛剧烈，红外线热成像温度变化可以作为临床诊断的指标之一。